Stock SOBI SWEDISH ORPHAN BIOVITRUM AB
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Swedish Orphan Biovitrum AB

Equities

SOBI

SE0000872095

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:30 2024-05-31 am EDT 		5-day change 1st Jan Change
282.4 SEK +1.66% Intraday chart for Swedish Orphan Biovitrum AB +0.79% +5.77%
May. 28 BerGenBio ASA Enter into A Clinical Trial Agreement with the Mays Cancer Center At the University of Texas Health Science Center At San Antonio and Swedish Orphan Biovitrum AB CI
May. 24 Sobi North America Gets FDA Fast Track Designation for Rheumatic Disease Complication Treatment DJ

Evolution of the average Target Price on Swedish Orphan Biovitrum AB

Price target over the last 5 years

History of analyst recommendation changes

2badb5ba33ed91.7e0NdGPari7yp6w1KKVWdG4Bz5isxocwlXGMHyLyxmM.rLxcLgyV5l-X_dZDHvcyMVszosD-hP4J2TfJcmut9AqBn3xFWpXxbaX_lA~afe2e7c73468af956140005350cfaff9

Analyst Recommendations on Swedish Orphan Biovitrum AB

Soaring dollar and oil spooks investors Our Logo
European shares edge higher as US CPI data looms, Credit Agricole gains RE
Swedish Orphan Biovitrum : Sobi publishes its Report for the Second Quarter 2015 - raises guidance GL
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
282.4 SEK
Average target price
320 SEK
Spread / Average Target
+13.31%
High Price Target
370 SEK
Spread / Highest target
+31.02%
Low Price Target
252 SEK
Spread / Lowest Target
-10.76%

Consensus detail

Consensus revision (last 18 months)

Ratings for Swedish Orphan Biovitrum AB

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. SOBI Stock
  4. Consensus Swedish Orphan Biovitrum AB